BT
CELG

Beacon Trust’s Celgene Corp CELG Stock Holding History

Beacon Trust’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$5.61M Sell
45,457
-467
-1% -$55.9K 0.88% 46
2016
Q4 		$5.32M Sell
45,924
-3,019
-6% -$336K 0.88% 47
2016
Q3 		$5.12M Sell
48,943
-13,884
-22% -$1.5M 0.86% 49
2016
Q2 		$6.2M Sell
62,827
-3,121
-5% -$323K 1.05% 34
2016
Q1 		$6.6M Sell
65,948
-2,799
-4% -$288K 1.15% 25
2015
Q4 		$8.23M Sell
68,747
-1,995
-3% -$231K 1.43% 19
2015
Q3 		$7.65M Sell
70,742
-14,488
-17% -$1.8M 1.35% 20
2015
Q2 		$9.86M Sell
85,230
-17,323
-17% -$1.98M 1.59% 15
2015
Q1 		$11.8M Sell
102,553
-1,329
-1% -$159K 1.8% 7
2014
Q4 		$11.6M Buy
103,882
+114
+0.1% +$12K 1.79% 6
2014
Q3 		$9.84M Sell
103,768
-4,372
-4% -$395K 1.63% 10
2014
Q2 		$9.29M Buy
108,140
+758
+0.7% +$57.6K 1.53% 11
2014
Q1 		$7.5M Buy
107,382
+2,460
+2% +$195K 1.28% 23
2013
Q4 		$8.86M Buy
104,922
+1,994
+2% +$158K 1.52% 12
2013
Q3 		$7.93M Sell
102,928
-666
-0.6% -$46.7K 1.47% 15
2013
Q2 		$6.06M Buy
+103,594
New +$6.23M 1.15% 28

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Beacon Trust's CELG Position: Q1 2017 in Review

Beacon Trust reduced its Celgene Corp (CELG) stake by 1% in Q1 2017, selling an estimated $55.9K and leaving 45,457 shares worth $5.61M. The position accounts for 0.88% of the portfolio, ranked #46.

Beacon Trust first reported a position in CELG in Q2 2013 and has held it in 16 quarters since. The position peaked at $11.8M in Q1 2015. 1,417 funds tracked by Wall St. Rank hold CELG as of Q1 2017.

  • Beacon Trust held 45,457 shares of Celgene Corp worth $5.61M as of Q1 2017.
  • Beacon Trust sold 467 Celgene Corp shares in Q1 2017, an estimated $55.9K.
  • Celgene Corp made up 0.88% of Beacon Trust's portfolio in Q1 2017, its #46 holding.
  • Beacon Trust first reported a position in Celgene Corp in Q2 2013 and has held it in 16 quarters since.
  • Beacon Trust's Celgene Corp position peaked at $11.8M in Q1 2015.
  • 1,417 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2017.

Based on Beacon Trust's 13F filing for Q1 2017, filed 9 May 2017.